MENU

PRTG Stock Portage Biotech (PRTG, $9.04) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 17, 2024

A.I.dvisor
at Tickeron.com
Loading...
PRTG - Portage Biotech Inc
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $9.04
Daily change: +$5.79 (+178.15%)
Daily volume: 36.5M
Capitalization: $10.1M
Industry: Biotechnology
This is a Bullish indicator signaling PRTG's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 49 similar cases where PRTG's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

PRTG in +201.33% Uptrend, rising for three consecutive days on December 17, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PRTG advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on PRTG as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRTG just turned positive on December 17, 2024. Looking at past instances where PRTG's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

PRTG moved above its 50-day moving average on December 17, 2024 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRTG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRTG broke above its upper Bollinger Band on December 17, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PRTG entered a downward trend on December 16, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.252) is normal, around the industry mean (14.664). P/E Ratio (0.173) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). PRTG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRTG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRTG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PRTG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Clarence Thomas Building
Phone
+1 203 221-7378
Employees
7
Web
https://www.portagebiotech.com